Resultados: 50

    Comprehensive, evidence-based, consensus guidelines for prescription of opioids for chronic non-cancer pain from the American Society of Interventional Pain Physicians (ASIPP)

    Pain physician; 7S (), 2023
    Opioid prescribing in the United States is decreasing, however, the opioid epidemic is continuing at an uncontrollable rate. Available data show a significant number of opioid deaths, primarily associated with illicit fentanyl use. It is interesting to also note that the data show no clear correlation be...

    AGA clinical practice guideline on the role of biomarkers for the management of Crohn’s Disease

    Gastroenterology; 6 (165), 2023
    Biomarkers are used frequently for evaluation and monitoring of patients with Crohn’s disease (CD). This American Gastroenterological Association (AGA) guideline is intended to support practitioners in decisions about the use of biomarkers for the management of CD. A multidisciplinary panel of content ...

    ESAIC focused guideline for the use of cardiac biomarkers in perioperative risk evaluation

    Eur. j. anaesthesiol; 40 (12), 2023
    In recent years, there has been increasing focus on the use of cardiac biomarkers in patients undergoing noncardiac surgery. The aim of this focused guideline was to provide updated guidance regarding the pre-, post- and combined pre-and postoperative use of cardiac troponin and B-type natriuretic peptid...

    Management of premenstrual Disorders ACOG clinical practice guideline nº 7

    Obstet. gynecol; 142 (6), 2023
    To provide recommendations for the management of premenstrual syndrome and premenstrual dysphoric disorder, collectively referred to as premenstrual disorders, based on assessment of the evidence regarding the safety and efficacy of available treatment options. An overview of the epidemiology, pathophysi...

    Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) for Use of Inactivated Vero Cell Culture-derived Japanese Encephalitis Vaccine in Children

    MMWR recomm. rep; 62 (45), 2023
    Inactivated Vero cell culture-derived Japanese encephalitis vaccine (JE-VC [manufactured as IXIARO]) is the only JE vaccine licensed and available in the United States. JE-VC is manufactured by Intercell Biomedical (Livingston, United Kingdom) and distributed in the United States private market by Novart...

    CDC recommendations for hepatitis C testing among perinatally exposed infants and children: United States, 2023

    MMWR recomm. rep; 72 (4), 2023
    The elimination of hepatitis C is a national priority (https://www.hhs.gov/sites/default/files/Viral-Hepatitis-NationalStrategic-Plan-2021-2025.pdf). During 2010–2021, hepatitis C virus (HCV) acute and chronic infections (hereinafter referred to as HCV infections) increased in the United States, conseq...

    Pancreatic cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up

    Ann. oncol; 34 (11), 2023
    The opportunity to detect pancreatic cancer (PC) when potentially curable depends on early diagnosis and an ability to identify and screen high-risk populations before symptoms arise. Identification of a high-risk population is challenging and optimal screening tools remain unclear.1 Older age is the str...

    Recurrent miscarriage: green-top guideline nº 17

    BJOG; 130 (12), 2023
    The purpose of this guideline is to provide guidance on the investigation and care of women and people with recurrent miscarriage.Within this document we use the terms woman and women's health. However, it is important to acknowledge that it is not only women for whom it is necessary to ...

    Antiplatelets and antithrombotics in neurointerventional procedures: guideline update

    J Neurointerv Surg; 15 (11), 2023
    Antiplatelet and antithrombotic medication management before, during, and after neurointerventional procedures has significant practice variation. This document updates and builds upon the 2014 Society of NeuroInterventional Surgery (SNIS) Guideline ’Platelet function inhibitor and platelet function te...

    Compounded bioidentical menopausal hormone therapy ACOG clinical consensus nº 6

    Obstet. gynecol; 142 (5), 2023
    Many compounding pharmacies use the phrase “bioidentical hormone” as a marketing term to imply that these preparations are natural and, thus, safer and more effective than U.S. Food and Drug Administration (FDA)–approved menopausal medications that use bioidentical or synthetic hormones or both. Ho...